๎
๎ผ
๋ก๊ทธ์ธ
๎
Liminatus Pharma Ord Shs Class A
LIMN0.177USD
-0.011-5.60%
์ข
๊ฐย 03/30, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
5.31M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ ํ์ฌ
Liminatus Pharma Ord Shs Class A ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ - -
ํ์ฌ ์ด๋ฆ- -
์์ฅ์ผ- -
CEO- -
์ง์ ์- -
์ ํ- -
ํ๊ณ ์ฐ๋ ์ข
๋ฃ- -
์ฃผ์- -
๋์- -
์ฆ๊ถ ๊ฑฐ๋์- -
๊ตญ๊ฐ- -
์ฐํธ ๋ฒํธ- -
์ ํ- -
์น์ฌ์ดํธ- -
์ข
๋ชฉ ์ฝ๋ - -
์์ฅ์ผ- -
CEO- -
Liminatus Pharma Ord Shs Class A์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sang-jin Daniel Lee
Mr. Sang-jin Daniel Lee
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong C. Yoo, Ph.D.
Dr. Byong C. Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Beom K. Choi
Mr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Director
Director
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
์์ต ๋ถ์
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Feb 19
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Valetudo Therapeutics LLC
15.68%
Feelux Co Ltd
6.78%
Iris Acquisition Holdings LLC
6.43%
Ewon Comfortech Co Ltd
3.81%
Red Peony Association 1st
3.74%
๊ธฐํ
63.55%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Valetudo Therapeutics LLC
15.68%
Feelux Co Ltd
6.78%
Iris Acquisition Holdings LLC
6.43%
Ewon Comfortech Co Ltd
3.81%
Red Peony Association 1st
3.74%
๊ธฐํ
63.55%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Corporation
43.91%
Hedge Fund
0.32%
Investment Advisor
0.27%
Investment Advisor/Hedge Fund
0.21%
๊ธฐํ
55.28%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Jan 21
๋ง์ง๋ง ์
๋ฐ์ดํธ: Wed, Jan 21
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2026Q4
13
261.92K
0.76%
--
2025Q4
19
240.79K
0.89%
-191.91K
2025Q3
21
261.92K
0.97%
-218.50K
2025Q2
19
204.70K
0.79%
-924.41K
2025Q1
11
--
0.00%
-1.16M
2024Q4
23
--
0.00%
-6.45M
2024Q3
70
16.83K
0.23%
-24.70M
2024Q2
75
146.55K
2.04%
-25.63M
2024Q1
79
231.31K
3.22%
-26.92M
2023Q4
79
236.25K
3.24%
-27.04M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Valetudo Therapeutics LLC
6.17M
22.8%
--
--
Jul 23, 2025
Feelux Co Ltd
4.00M
14.78%
--
--
Jul 23, 2025
Iris Acquisition Holdings LLC
6.90M
25.49%
--
--
Jul 23, 2025
Ewon Comfortech Co Ltd
1.50M
5.54%
--
--
Jul 23, 2025
Red Peony Association 1st
1.47M
5.43%
--
--
Jul 23, 2025
Nongae Apple Association 1st
1.47M
5.43%
--
--
Jul 23, 2025
The Vanguard Group, Inc.
73.42K
0.27%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
63.73K
0.24%
-107.00
-0.17%
Sep 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎์ด๋ฆ
๋น์จ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
